Biontech boss Uğur Şahin sees medication on the suitable path to “controlling or ideally curing cancer in the long term”. “In principle, I see no reason why many types of cancer should not be detectable earlier and easier to cure,” Şahin informed the news journal “Der Spiegel” after a report on Sunday.
The background is a growth that Şahin calls “the great knowledge revolution” – an ever quicker spiral of progress and growth leaps, pushed by digital applied sciences and synthetic intelligence. “Everything happens much, much faster today than it used to,” stated the researcher and firm boss. “To gain insights, to confirm them, to apply them.”
First most cancers medicine as early as 2026?
Şahin has been researching most cancers for many years and is a professor of experimental oncology on the Mainz University Medical Center. The firm he based, Biontech , is at present researching virtually 30 new most cancers therapies and depends specifically on synthetic intelligence.
From 2026, Şahin hopes that the primary drugs shall be prepared for approval. “We want to have a large portfolio of cancer therapies on the market by 2030,” stated the Biontech boss on the event of World Cancer Day.
Source: www.nationalturk.com
